DCPrime
ID: 5368563DCPrime is a biotechnology company developing cancer immunotherapies.
5
Funding Rounds
$26.0m
Money raised
Overview
DCPrime is a biotechnology company developing cancer immunotherapies.
- Website:
- Business model: B2B B2C
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Dr* Ad* Kr******* | - | - | - |
Funding
Funding series
Funding Series Analysis
The company DCPrime has raised a total of $25.98m in funding over 5 rounds.
Key Insights:
- DCPrime Venture round, March 2018: $18.6m
- DCPrime Grant (money), January 2016: $6.06m
- DCPrime Private equity, July 2015: $1.32m
Industries
DCPrime is active in the following industries: